Search Results | American Association for Cancer Research

1-20 of 46

2 3

Sort by

Sort Order Select

Journal Articles

Farnesyl Transferase Inhibitors for Patients with Lung Cancer

Bruce E. Johnson, John V. Heymach

Clin Cancer Res (2004) 10 (12): 4254s–4257s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040016

Published: 01 September 2009

View article

Journal Articles

Clinical Trial Design Issues in the Era of Targeted Therapies

Joan H. Schiller

Clin Cancer Res (2004) 10 (12): 4281s–4282s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040008

Published: 01 September 2009

View article

Journal Articles

The Role of Erlotinib (Tarceva, OSI 774) in the Treatment of Non-Small Cell Lung Cancer

Roman Perez-Soler

Clin Cancer Res (2004) 10 (12): 4238s–4240s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040017

Published: 01 September 2009

View article

Journal Articles

The Potential Role of Proteasome Inhibitors in the Treatment of Lung Cancer

Paul A. Bunn, Jr.

Clin Cancer Res (2004) 10 (12): 4263s–4265s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040011

Published: 01 September 2009

View article

Journal Articles

Cetuximab in Advanced Non-Small Cell Lung Cancer

Ramaswamy Govindan

Clin Cancer Res (2004) 10 (12): 4241s–4244s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040015

Published: 01 September 2009

View article

Journal Articles

Cyclooxygenase as a Target in Lung Cancer

Joanne R. Brown, Raymond N. DuBois

Clin Cancer Res (2004) 10 (12): 4266s–4269s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040014

Published: 01 September 2009

View article

Journal Articles

Gene Expression as a Predictive Marker of Outcome in Stage IIB-IIIA-IIIB Non-Small Cell Lung Cancer After Induction Gemcitabine-Based Chemotherapy Followed By Resectional Surgery

Rafael Rosell, Enriqueta Felip, Miquel Taron, Joaquim Majo, Pedro Mendez, Maria Sanchez-Ronco, Cristina Queralt, Jose Javier Sanchez, Jose Maestre

Clin Cancer Res (2004) 10 (12): 4215s–4219s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040006

Published: 01 September 2009

View article

Journal Articles

Pemetrexed (ALIMTA), A Novel Multitargeted Antineoplastic Agent

Alex A. Adjei

Clin Cancer Res (2004) 10 (12): 4276s–4280s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040010

Published: 01 September 2009

View article

Journal Articles

CME Assessment Test

Clin Cancer Res (2004) 10 (12): 4283s–4284s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040027

Published: 01 September 2009

View article

Journal Articles

Sponsorship and CME Credit

Clin Cancer Res (2004) 10 (12): ii–iii.

DOI: https://doi.org/10.1158/1078-0432.CCR-040026

Published: 01 September 2009

View article

Journal Articles

Novel Agents in the Treatment of Lung Cancer: Conference Summary Statement

Thomas J. Lynch, Alex A. Adjei, Paul A. Bunn, Jr., Raymond N. DuBois, David R. Gandara, Giuseppe Giaccone, Ramaswamy Govindan, Roy S. Herbst, Bruce E. Johnson, Fadlo R. Khuri, Roman Perez-Soler, Rafael Rosell, Eric K. Rowinsky, Alan B. Sandler, Giorgio V. Scagliotti, Joan H. Schiller, Geoffrey I. Shapiro, Mark A. Socinski, Carol S. Hart

Clin Cancer Res (2004) 10 (12): 4199s–4204s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040021

Published: 01 September 2009

View article

Journal Articles

Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of Standard Treatment Paradigms

Mark A. Socinski

Clin Cancer Res (2004) 10 (12): 4210s–4214s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040009

Published: 01 September 2009

View article

Journal Articles

The Role of Gefitinib in Lung Cancer Treatment

Giuseppe Giaccone

Clin Cancer Res (2004) 10 (12): 4233s–4237s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040005

Published: 01 September 2009

View article

Journal Articles

Conference Participants

Clin Cancer Res (2004) 10 (12): i.

DOI: https://doi.org/10.1158/1078-0432.CCR-040025

Published: 01 September 2009

View article

Journal Articles

Oblimersen Sodium (Genasense bcl-2 Antisense Oligonucleotide): A Rational Therapeutic to Enhance Apoptosis in Therapy of Lung Cancer

Roy S. Herbst, Stanley R. Frankel

Clin Cancer Res (2004) 10 (12): 4245s–4248s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040018

Published: 01 September 2009

View article

Journal Articles

The Biology of Epidermal Growth Factor Receptor in Lung Cancer

Giorgio V. Scagliotti, Giovanni Selvaggi, Silvia Novello, Fred R. Hirsch

Clin Cancer Res (2004) 10 (12): 4227s–4232s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040007

Published: 01 September 2009

View article

Journal Articles

Molecularly Targeted Approaches to the Chemoprevention of Lung Cancer

Fadlo R. Khuri, Victor Cohen

Clin Cancer Res (2004) 10 (12): 4249s–4253s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040019

Published: 01 September 2009

View article

Journal Articles

Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer

Alan B. Sandler, David H. Johnson, Roy S. Herbst

Clin Cancer Res (2004) 10 (12): 4258s–4262s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040023

Published: 01 September 2009

View article

Journal Articles

Preclinical and Clinical Development of the Cyclin-Dependent Kinase Inhibitor Flavopiridol

Geoffrey I. Shapiro

Clin Cancer Res (2004) 10 (12): 4270s–4275s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040020

Published: 01 September 2009

View article

Journal Articles

Curtailing the High Rate of Late-Stage Attrition of Investigational Therapeutics Against Unprecedented Targets in Patients with Lung and Other Malignancies

Eric K. Rowinsky

Clin Cancer Res (2004) 10 (12): 4220s–4226s.

DOI: https://doi.org/10.1158/1078-0432.CCR-040013

Published: 01 September 2009

View article

2 3

NARROW

Farnesyl Transferase Inhibitors for Patients with Lung Cancer

Clinical Trial Design Issues in the Era of Targeted Therapies

The Role of Erlotinib (Tarceva, OSI 774) in the Treatment of Non-Small Cell Lung Cancer

The Potential Role of Proteasome Inhibitors in the Treatment of Lung Cancer

Cetuximab in Advanced Non-Small Cell Lung Cancer

Cyclooxygenase as a Target in Lung Cancer

Gene Expression as a Predictive Marker of Outcome in Stage IIB-IIIA-IIIB Non-Small Cell Lung Cancer After Induction Gemcitabine-Based Chemotherapy Followed By Resectional Surgery

Pemetrexed (ALIMTA), A Novel Multitargeted Antineoplastic Agent

CME Assessment Test

Sponsorship and CME Credit

Novel Agents in the Treatment of Lung Cancer: Conference Summary Statement

Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of Standard Treatment Paradigms

The Role of Gefitinib in Lung Cancer Treatment

Conference Participants

Oblimersen Sodium (Genasense bcl-2 Antisense Oligonucleotide): A Rational Therapeutic to Enhance Apoptosis in Therapy of Lung Cancer

The Biology of Epidermal Growth Factor Receptor in Lung Cancer

Molecularly Targeted Approaches to the Chemoprevention of Lung Cancer

Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer

Preclinical and Clinical Development of the Cyclin-Dependent Kinase Inhibitor Flavopiridol

Curtailing the High Rate of Late-Stage Attrition of Investigational Therapeutics Against Unprecedented Targets in Patients with Lung and Other Malignancies

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only